GlobalData: Meat substitutes will continue to be on demand as 5% of consumers identify as ‘flexitarian’

GlobalData: Meat substitutes will continue to be on demand as 5% of consumers identify as ‘flexitarian’

Heart-healthy diet is low in cholesterol, says AHA yet again Impossible Foods will continue to lead the market in meat substitutes with the launch of its new plant-based pork. With pork being the most widely consumed meat in the world, this new launch is vital in the company’s mission to change the way we eat. The Silicone Valley based company unveiled their plant-based innovation at the CES gadget show in Las Vegas and under the increasingly popular ‘Veganuary’, a period that is seeing many consumers and brands alike promoting the trial and awareness of a plan-based lifestyle. Questier continues: Although launching primarily in the US, the plant-based pork ‘meat’ could potentially have a huge impact in China, the country that consumes more pork than any other. Impossible Foods has also developed a ground pork variant that can be used as a substitute in many dishes, ensuring that their product can be easily adapted to different consumer requirements.” In another ‘Veganuary’ product promotion, McDonald’s launched its Vegan Dipper Meal at the start of the year which suffered some backlash. The dippers, which usually contain chicken, instead comprised red pepper, pesto and split peas. Some consumers have been vocal about their disappointment that the dippers did not contain a meat substitute. Questier concludes: With brand and retailer commitment and consumer rejection of more generic vegetable products, consumers’ tastes are becoming increasingly sophisticated.” Source:



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More